Research Paper Volume 16, Issue 2 pp 1712—1732
Malignant cell receptor-ligand subtypes guide the prediction of prognosis and personalized immunotherapy of liver cancer
Figure 9. Relationship between RiskScore and immunity. (A) Correlation analysis of RiskScore and immune score. (B) Comparison of 28 immune cell scores in high and low risk groups. (C) Correlation analysis of RiskScore for TIDE. (D) Comparison of immune checkpoint expression in high and low risk groups. (E) Comparison of tumor reactivity scores in high and low risk groups. (F) Th1/IFNγ score comparison between high and low risk group.